DiaMedica anticipates top line data for Part 1A in the first half of 2025 which is expected to demonstrate initial proof-of-concept including whether DM199 is safe and lowers blood pressure.

While medical headlines often focus on the biochemical underpinnings of disease, our body's biomechanics are equally crucial.

A simple biomaterial-based strategy that can influence the behavior of cells could pave the way for more effective medical ...

Ongoing fundamental research on cancer cells could be used to create new drugs and therapies that fight the spread of cancer ...

The ability of the bone marrow to produce healthy blood cells declines significantly with age, leading to age-related ...